Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8459 Cr | ₹854 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.27 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | -1.62% | -1.7% |
| 6 Month | 1.58% | 3.61% |
| 1 Year | -1.45% | -2.45% |
| 3 Year | 21.6% | 21.07% |
| 5 Year | 15.35% | 13.62% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | -1.66% | -2.18% |
| 1 Year | 2.66% | 2.15% |
| 3 Year | 15.82% | 15.32% |
| 5 Year | 16.04% | 15.05% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 16.62% | 21.73% |
| 3 Year | 20.93% | 17.27% |
| 5 Year | 20.36% | 19.95% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 16.02% |
| Sharp | 0.98% | 0.85% |
| Beta | 0.87% | 0.96% |
| Alpha | 1.45% | -1.71% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Funds Managed | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 1.34 | 2.33 |
| Mid Cap | 35.32 | 40.96 |
| Small Cap | 30.74 | 29.58 |
| Large Cap | 32.6 | 27.13 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 0.55 | 2.33 |
| Healthcare | 99.45 | 96.8 |
| Basic Materials | - | 0.87 |
Top Comparisons
Mahindra Manulife Aggressive Hybrid Fund - Regular Plan - Growth
3Y Returns16.32%
HSBC Aggressive Hybrid Fund - Regular Growth
3Y Returns15.07%
SBI ELSS Tax Saver Fund - Regular Plan- Growth
3Y Returns22.59%
360 ONE ELSS Nifty 50 Tax Saver Index Fund Regular - Growth
3Y Returns0%
Mirae Asset Equity Savings Fund- Regular Plan- Growth
3Y Returns10.98%
Axis Equity Savings Fund - Regular Plan - Growth
3Y Returns9.99%
SBI Conservative Hybrid Fund - Regular Plan - Growth
3Y Returns9.66%
HSBC Conservative Hybrid Fund - Regular Growth
3Y Returns9.33%